J Korean Soc Vasc Surg.  2003 May;19(1):49-56.

Follow-up Results in Patients Underwent Axillo-femoral Bypass for Aortoiliac Occlusive Disease

Affiliations
  • 1Division of Vascular Surgery, Department of Surgery, School of Medicine, Kyungpook National University, Daegu, Korea. dikim@smc.samsung.co.kr

Abstract

PURPOSE
Axillofemoral bypass for aortoiliac occlusive disease is a type of extra-anatomic bypass with varying reputations. This study was performed to observe early and late outcomes in patients underwent axillofemoral bypasses. METHOD: We retrospectively reviewed 25 patients who underwent 16 elective and 9 emergent axillofemoral bypasses. Mean age of patients was 72.5 years. Coexisting medical conditions included hypertension in 44%, ischemic heart disease in 28%, diabetes in 20%, chronic obstructive pulmonary disease in 20%, malignant tumor in 12% and cerebrovascular disease in 8%. All patients were presented with critical leg ischemia except for 2 with short-distance claudication. Axillofemoral bypass was performed under general anesthesia making configuration of inverted C shaped femoro-femoral bypass and redundant axillo-femoral limb using 8 mm ringed PTFE graft. RESULT: Two operative mortality occurred after emergent operations. Long-term folow-up results revealed 1 and 3 year primary graft patencies were 88% and 36% in the emergent operation group and 75% and 56% in the elective operation group. Limb salvage rates were 92% and 87% at 1 and 3 years respectively. Patient survival at 1 and 3 years after bypass operations were 78%, 22% in the emergent operation group and 86% and 54% in the elective operation group respectively. However, the differences between these 2 groups were not statistically significant.
CONCLUSION
After performing 16 elective and 9 emergent axillofemoral bypasses for patients with higher surgical risk and poor distal runoff arteries, we experienced rather higher operative mortality, leg amputation rates and poor follow-up results. However, in the case of very high risk patients with no other treatment option, axillofemoral bypass can be, not only a limb saving, but a life saving procedure.

Keyword

Axillofemoral bypass; Patency; Survival

MeSH Terms

Amputation
Anesthesia, General
Arteries
Extremities
Follow-Up Studies*
Humans
Hypertension
Ischemia
Leg
Limb Salvage
Mortality
Myocardial Ischemia
Polytetrafluoroethylene
Pulmonary Disease, Chronic Obstructive
Retrospective Studies
Transplants
Polytetrafluoroethylene
Full Text Links
  • JKSVS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr